首页> 美国卫生研究院文献>Stem Cell Research Therapy >Developing neural stem cell-based treatments for neurodegenerative diseases
【2h】

Developing neural stem cell-based treatments for neurodegenerative diseases

机译:开发基于神经干细胞的神经退行性疾病治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Owing to the aging of the population, our society now faces an impending wave of age-related neurodegenerative pathologies, the most significant of which is Alzheimer’s disease. Currently, no effective therapies for Alzheimer’s disease have been developed. However, recent advances in the fields of neural stem cells and human induced pluripotent stem cells now provide us with the first real hope for a cure. The recent discovery by Blurton-Jones and colleagues that neural stem cells can effectively deliver disease-modifying therapeutic proteins throughout the brains of our best rodent models of Alzheimer’s disease, combined with recent advances in human nuclear reprogramming, stem cell research, and highly customized genetic engineering, may represent a potentially revolutionary personalized cellular therapeutic approach capable of effectively curing, ameliorating, and/or slowing the progression of Alzheimer’s disease.
机译:由于人口的老龄化,我们的社会现在面临着与年龄有关的神经退行性病变的浪潮,其中最重要的是阿尔茨海默氏病。目前,尚未开发出用于治疗阿尔茨海默氏病的有效疗法。但是,神经干细胞和人类诱导的多能干细胞领域的最新进展为我们提供了治疗的第一个真正希望。 Blurton-Jones及其同事最近的发现是,神经干细胞可以有效地将疾病改善性治疗蛋白传递到我们最佳的阿尔茨海默氏病啮齿动物模型的大脑中,并结合了人类核重编程,干细胞研究和高度定制的遗传学方面的最新进展工程,可能代表一种潜在的革命性的个性化细胞治疗方法,能够有效治愈,改善和/或减缓阿尔茨海默氏病的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号